Tango Therapeutics, Inc.
TNGX
Classement en actions
#4544
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Prix de l'action
$27.18
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$3.38B
Changement (1 jour)
-1.41%
Changement (1 an)
202.34%
Pays
US
Échange Tango Therapeutics, Inc. (TNGX)
Catégorie
Healthcare
Ratio P/S pour Tango Therapeutics, Inc. (TNGX)
Ratio P/S au October 2026 TTM : 67.14
Selon les derniers rapports financiers et le cours de l'action de Tango Therapeutics, Inc., le ratio cours/ventes actuel (TTM) est 67.14. À la fin de 2023, le ratio P/S était de 25.63.
Historique du ratio P/S pour Tango Therapeutics, Inc. de 2019 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 67.14 | 737.15% |
| 2024 | 8.02 | -68.70% |
| 2023 | 25.63 | 0.08% |
| 2022 | 25.61 | 39.62% |
| 2021 | 18.34 | -61.56% |
| 2020 | 47.71 | 1,179.46% |
| 2019 | 3.73 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 10.02 | -85.07% |
US
|
|
| 40.55 | -39.60% |
US
|
|
| 3.96 | -94.10% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -84.89% |
NL
|
